Refine
Year of publication
- 2015 (75) (remove)
Document Type
- Article (45)
- Doctoral Thesis (19)
- Conference Proceeding (4)
- Review (4)
- Postprint (2)
- Preprint (1)
Is part of the Bibliography
- yes (75)
Keywords
- Endothelin (3)
- Inflammation (2)
- Solanaceae (2)
- Sphingosine kinase (2)
- cells (2)
- coenzyme-a (2)
- database (2)
- energy-metabolism (2)
- glutathione (2)
- hallervorden-spatz-syndrome (2)
- inflammation (2)
- mobility-mass spectrometry (2)
- model (2)
- neurodegeneration (2)
- neurotoxicity (2)
- type 2 diabetes (2)
- 1-Phenylethanol (1)
- 2-Phenylethanol (1)
- 3,5-Dimethoxytoluene (1)
- ADPKD (1)
- AOAC (1)
- APOM protein (1)
- Abrus precatorius (1)
- Acid sphingomyelinase (1)
- Adipositas (1)
- Akt signaling (1)
- Alcohol dependence (1)
- Alkohol (1)
- Alpine metamorphism (1)
- Antibiotikaresistenz (1)
- Anxiety (1)
- Apoptosis (1)
- Arsenolipids (1)
- Aryl-hydrocarbon receptor (1)
- BMP4 (1)
- BPA (1)
- Beta-amylase (1)
- Bioaktivität (1)
- Bioavailability (1)
- Biomarker (1)
- Bisphenol A (1)
- Blood platelets (1)
- Brassicaceae (1)
- Caco-2 intestinal barrier model (1)
- Caenorhabditis elegans (1)
- Camellia sinensis (1)
- Cameroon (1)
- Cardiovascular (1)
- Carotenoid (1)
- Case-control study (1)
- Catechins (1)
- Ceramide (1)
- Chronic kidney disease (1)
- Clinical (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colon cancer (1)
- Connective tissue growth factor (1)
- Cyp2b1 (1)
- Cytotoxicity (1)
- DNA methylation (1)
- Darmbakterium (1)
- Dengue (1)
- Depression (1)
- Development (1)
- Diabetic cardiomyopathy (1)
- Diabetic nephropathy (1)
- Diagnostic (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Disease (1)
- Doehlert design (1)
- Dopamine (1)
- Drug metabolism (1)
- ET-1 (1)
- ETA (1)
- ETB (1)
- Endocrine disruption (1)
- Endothelial cells (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Epigenetic (1)
- Equol (1)
- Extraction (1)
- Fabaceae (1)
- Fibrosis (1)
- Firefly luciferase inhibition (1)
- Floral scent compound (1)
- Food Chain (1)
- Freeze-fracturing (1)
- Gastrointestinal tract (1)
- Gene expression (1)
- Geschmacksrezeptor (1)
- Glucagon (1)
- Glycerophospholipids (1)
- HEK293 (1)
- HPLC (1)
- Hepatotoxicity (1)
- High pressure - low temperature treatments (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Hypoxia (1)
- IGF-1 (1)
- Insulin-induzierte Hypoglykämie (1)
- Isoflavone (1)
- Isotope-dilution analysis (1)
- Kinetik (1)
- Körpergewichsterhalt (1)
- Körpergewichtsverlust (1)
- Lebensmittelkette (1)
- Life science (1)
- Lipid (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Lu-Hf geochronology (1)
- Lysophosphatidylcholines (1)
- MRSA (1)
- Manganese (1)
- Mass spectrometry (1)
- Membrane (1)
- Menderes Massif (1)
- Mercuric mercury (1)
- Mesoangioblasts (1)
- Methylmercury (1)
- Mice (1)
- Micellar caseins (1)
- Microbial degradation (1)
- Migration (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Morphogenesis (1)
- Motor coordination (1)
- Multiple herbivory (1)
- Myoblasts (1)
- Myzus persicae (1)
- Neurotoxicity (1)
- Nitric oxide (1)
- Nuclear receptor (1)
- Oxidative stress (1)
- PBPK (1)
- PBTK (1)
- Pea flour (1)
- Pea protein isolate (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Phenylpropanoids (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Physicochemical properties (1)
- Plasma (1)
- Plasmalogens (1)
- Polymorphismus (1)
- Prediabetes (1)
- Presystemic metabolism (1)
- Procyanidins (1)
- Proteine (1)
- Pulmonary arterial hypertension (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- Reduktase (1)
- Relaxin (1)
- Resistance (1)
- Rezeptorscreening (1)
- Rosa x level (1)
- S1P(3) receptor (1)
- SU5416 (1)
- Serotonin (1)
- Short chain dehydrogenase (1)
- Solanum lycopersicum (1)
- Spectrophotometry (1)
- Sphingolipids (1)
- Sphingomyelin (1)
- Sphingosine 1phosphate (1)
- Structural changes (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- TTC (1)
- Tandem mass spectrometry (1)
- Tas1r1 (1)
- Technofunctional properties (1)
- Tetranychus urticae (1)
- Thiomersal (1)
- Three phase partitioning (1)
- Thyroid hormone (1)
- ToF-SIMS imaging (1)
- Toxicity (1)
- Toxikokinetik (1)
- Transactivation assay (1)
- Transcriptomics (1)
- Transforming growth factor beta (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- UDP-glucuronosyltransferase (1)
- Volatile compound (1)
- Whey proteins (1)
- Xenobesity (1)
- Yolk (1)
- acid sphingomyelinase (1)
- acute kidney injury (1)
- albuminuria (1)
- alcohol (1)
- aphids (1)
- atherosclerosis (1)
- auditory neurons (1)
- bioactivity (1)
- body weight loss (1)
- body weight maintenance (1)
- carotenoids (1)
- carotenoids bioavailability (1)
- ceramide (1)
- chronic kidney disease (1)
- crop (1)
- differentiation (1)
- equol (1)
- first trimester (1)
- garnet (1)
- genomics (1)
- gestational diabetes mellitus (GDM) (1)
- glucagon (1)
- glycaemic control (1)
- gut microbiota (1)
- high-density lipoprotein (HDL) (1)
- hypertension (1)
- iCheck (1)
- in silico (1)
- insulin (1)
- insulin-induced hypoglycemia (1)
- integrins (1)
- isoflavones (1)
- kidney dysfunction (1)
- kinetics (1)
- large for gestational age fetus (LGA) (1)
- linagliptin (1)
- metabolomics (1)
- microbiomics (1)
- micronutrient deficiencies (1)
- obesity (1)
- plant volatiles (1)
- platelets (1)
- polycystic kidney disease (1)
- polymorphism (1)
- proliferation (1)
- protein (1)
- protein microheterogeneity (1)
- proteomics (1)
- reductase (1)
- retinol (ROH) (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- sphingolipids (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- survival (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- systemic response (1)
- taste receptor (1)
- taste receptor screening (1)
- terpenoids (1)
- toxicology (1)
- transcriptomics (1)
- transthyretin (TTR) (1)
- tumor-metastasis (1)
- type 2 diabetes mellitus (1)
- umami (1)
- vitamin A deficiency (1)
- zinc/iron supplementation (1)
- Übertragung (1)
Institute
- Institut für Ernährungswissenschaft (75) (remove)
Inflammation in Cachexia
(2015)
Dopamine (DA) and serotonin (SRT) are monoamine neurotransmitters that play a key role in regulating the central and peripheral nervous system. Their impaired metabolism has been implicated in several neurological disorders, such as Parkinson's disease and depression. Consequently, it is imperative to monitor changes in levels of these low-abundant neurotransmitters and their role in mediating disease. For the first time, a rapid, specific and sensitive isotope-dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of DA and SRT in the nematode Caenorhabditis elegans (C. elegans). This model organism offers a unique approach for studying the effect of various drugs and environmental conditions on neurotransmitter levels, given by the conserved DA and SRT biology, including synaptic release, trafficking and formation. We introduce a novel sample preparation protocol incorporating the usage of sodium thiosulfate in perchloric acid as extraction medium that assures high recovery of the relatively unstable neurotransmitters monitored. Moreover, the use of both deuterated internal standards and the multiple reaction monitoring (MRM) technique allows for unequivocal quantification. Thereby, to the best of our knowledge, we achieve a detection sensitivity that clearly exceeds those of published DA and SRT quantification methods in various matrices. We are the first to show that exposure of C elegans to the monoamine oxidase B (MAOB) inhibitor selegiline or the catechol-O-methyltransferase (COMT) inhibitor tolcapone, in order to block DA and SRT degradation, resulted in accumulation of the respective neurotransmitter. Assessment of a behavioral output of the dopaminergic system (basal slowing response) corroborated the analytical LC-MS/MS data. Thus, utilization of the C elegans model system in conjunction with our analytical method is well-suited to investigate drug-mediated modulation of the DA and SRT system in order to identify compounds with neuroprotective or regenerative properties. (C) 2015 Elsevier B.V. All rights reserved.
Aufgrund ihrer potenziell gesundheitsfördernden Wirkung sind die polyphenolischen Isoflavone für die menschliche Ernährung von großem Interesse. Eine Vielzahl an experimentellen und epidemiologischen Studien zeigen für die in Soja enthaltenen Isoflavone Daidzein und Genistein eine präventive Wirkung bezüglich hormon-abhängiger und altersbedingter Erkrankungen, wie Brust- und Prostatakrebs, Osteoporose, Herz-Kreislauf-Erkrankungen sowie des menopausalen Syndroms. Die Metabolisierung und Bioaktivierung dieser sekundären Pflanzenstoffe durch die humane intestinale Darmmikrobiota ist individuell unterschiedlich. Nur in einem geringen Teil der westlichen Bevölkerung wird der Daidzein-Metabolit Equol durch spezifische Darmbakterien gebildet. Ein isoliertes Equol-produzierendes Bakterium des menschlichen Darmtrakts ist Slackia isoflavoniconvertens. Anhand dieser Spezies sollten die bislang unbekannten, an der Umsetzung von Daidzein und Genistein beteiligten Enzyme identifiziert und charakterisiert werden.
Fermentationsexperimente mit S. isoflavoniconvertens zeigten, dass die Gene der Daidzein und Genistein-umsetzenden Enzyme nicht konstitutiv exprimiert werden, sondern induziert werden müssen. Mit Hilfe der zweidimensionalen differentiellen Gelelektrophorese wurden sechs Proteine detektiert, welche in einer S. isoflavoniconvertens-Kultur in Anwesenheit von Daidzein induziert wurden. Auf Grundlage einzelner Peptidsequenzen erfolgte die Sequenzierung eines Genkomplexes mit den in gleicher Orientierung angeordneten Genen der durch Daidzein induzierten Proteine. Sequenzvergleiche identifizierten zudem äquivalente Genprodukte zu den Proteinen von S. isoflavoniconvertens in anderen Equolproduzierenden Bakterien. Nach der heterologen Expression in Escherichia coli wurden drei dieser Gene durch enzymatische Aktivitätstests als Daidzein-Reduktase (DZNR), Dihydrodaidzein-Reduktase (DHDR) und Tetrahydrodaidzein-Reduktase (THDR) identifiziert. Die Kombination der E. coli-Zellextrakte führte zur vollständigen Umsetzung von Daidzein über Dihydrodaidzein zu Equol. Neben Daidzein setzte die DZNR auch Genistein zu Dihydrogenistein um. Dies erfolgte mit einer größeren Umsatzgeschwindigkeit im Vergleich zur Reduktion von Daidzein zu Dihydrodaidzein. Enzymatische Aktivitätstests mit dem Zellextrakt von S. isoflavoniconvertens zeigten ebenfalls eine schnellere Umsetzung von Genistein. Die Kombination der rekombinanten DHDR und THDR führte zur Umsetzung von Dihydrodaidzein zu Equol. Der korrespondierende Metabolit 5-Hydroxyequol konnte als Endprodukt des Genistein-Metabolismus nicht detektiert werden. Zur Reinigung der drei identifizierten Reduktasen wurden diese genetisch an ein Strep-tag fusioniert und mittels Affinitätschromatographie gereinigt. Die übrigen durch Daidzein induzierten Proteine IfcA, IfcBC und IfcE wurden ebenfalls in E. coli exprimiert und als Strep-Fusionsproteine gereinigt. Vergleichende Aktivitätstests identifizierten das induzierte Protein IfcA als Dihydrodaidzein-Racemase. Diese katalysierte die Umsetzung des (R)- und (S)-Enantiomers von Dihydrodaidzein und Dihydrogenistein zum korrespondierenden Racemat. Neben dem Elektronentransfer-Flavoprotein IfcBC wurden auch die THDR, DZNR und IfcE als FAD-haltige Flavoproteine identifiziert. Zudem handelte es sich bei IfcE um ein Eisen-Schwefel-Protein. Nach Induktion der für die Daidzein-Umsetzung kodierenden Gene wurden mehrere verschieden lange mRNA-Transkripte gebildet. Dies zeigte, dass die Transkription des durch Daidzein induzierten Genkomplexes in S. isoflavoniconvertens nicht in Form eines einzelnen Operonsystems erfolgte.
Auf Grundlage der identifizierten Daidzein-umsetzenden Enzyme kann der Mechanismus der bakteriellen Umsetzung von Isoflavonen durch S. isoflavoniconvertens eingehend erforscht werden. Die ermittelten Gensequenzen der durch Daidzein induzierten Proteine sowie die korrespondierenden Gene weiterer Equol-produzierender Bakterien bieten zudem die Möglichkeit der mikrobiellen Metagenomanalyse im humanen Darmtrakt.
Xenobiotics may interfere with the hypothalamic-pituitary-thyroid endocrine axis by inducing enzymes that inactivate thyroid hormones and thereby reduce the metabolic rate. This induction results from an activation of xeno-sensing nuclear receptors. The current study shows that benzo[a]pyrene, a frequent contaminant of processed food and activator of the arylhydrocarbon receptor (AhR) activated the promoter and induced the transcription of the nuclear receptor constitutive androstane receptor (CAR, NR1I3) in rat hepatocytes. Likewise, phenobarbital induced the AhR transcription. This mutual induction of the nuclear receptors enhanced the phenobarbital-dependent induction of the prototypic CAR target gene Cyp2b1 as well as the AhR-dependent induction of UDP-glucuronosyltransferases. In both cases, the induction by the combination of both xenobiotics was more than the sum of the induction by either substance alone. By inducing the AhR, phenobarbital enhanced the benzo[a]pyrene-dependent reduction of thyroid hormone half-life and the benzo[a]pyrene-dependent increase in the rate of thyroid hormone glucuronide formation in hepatocyte cultures. CAR ligands might thus augment the endocrine disrupting potential of AhR activators by an induction of the AhR. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
This study shows Lu-Hf geochronology of zoned garnet crystals contained in mica schists from the southern Menderes Massif, Turkey. Selected samples are four 3-5 cm large garnet megacrysts of which several consecutive garnet shells have been sampled with a micro-saw and analyzed for dating. The results are used to extract growth rates of garnet, and also to improve the time constraint for Alpine-aged overprint of the Pan-African basement in the Menderes Massif.
The new data provides a precise age determination for prograde Barrovian metamorphism in the southern Menderes Massif, which so far was placed between 63 and 27 Ma on the basis of mica Rb-Sr and Ar-Ar dating. This study provides new constraints crucial to the understanding of the tectonic evolution of southwest Anatolia and the Aegean realm, as it yields a shorter outline for Alpine aged continental collision.
Die Phyllosphäre
(2015)
Pulmonary arterial hypertension (PAH) is a fatal disease that eventually results in right heart failure and death. Current pharmacologic therapies for PAH are limited, and there are no drugs that could completely cure PAH. Enhanced activity of endothelin system has been implicated in PAH severity and endothelin receptor antagonists have been used clinically to treat PAH. However, there is limited experimental evidence on the direct role of enhanced endothelin system activity in PAL-I. Here, we investigated the correlation between endothelin-1 (ET-1) and PAH using ET-1 transgenic (ETTG) mice. Exposure to chronic hypoxia increased right ventricular pressure and pulmonary arterial wall thickness in ETTG mice compared to those in wild type mice. Of note, ETTG mice exhibited modest but significant increase in right ventricular pressure and vessel wall thickness relative to wild type mice even under normoxic conditions. To induce severe PAH, we administered SU5416, a vascular endothelial growth factor receptor inhibitor, combined with exposure to chronic hypoxia. Treatment with SU5416 modestly aggravated hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and pulmonary arterial vessel wall thickening in ETTG mice in association with increased interleukin-6 expression in blood vessels. However, there was no sign of obliterative endothelial cell proliferation and plexiform lesion formation in the lungs. These results demonstrated that enhanced endothelin system activity could be a causative factor in the development of PAH and provided rationale for the inhibition of endothelin system to treat PAH. (C) 2015 Elsevier Inc. All rights reserved.
The relationship between nutrition and the development of chronic diseases including metabolic syndrome, diabetes mellitus, cancer and cardiovascular disease has been well studied. On the other hand, changes in the GH-IGF-1 axis in association with nutrition-related diseases have been reported. The interplay between GH, total IGF-1 and different inhibitory and stimulatory kinds of IGF-1 binding proteins (IGFBPs) results in IGF-1 bioactivity, the ability of IGF-1 to induce phosphorylation of its receptor and consequently its signaling. Moreover, IGF-1 bioactivity is sufficient to reflect any change in the GH-IGF-1 system. Accumulating evidence suggests that both of high protein diet, characterized by increased glucagon secretion, and insulin-induced hypoglycemia increase mortality rate and the mechanisms are unclear. However both of glucagon and insulin-induced hypoglycemia are potent stimuli of GH secretion. The aim of the current study was to identify the impact of glucagon and insulin-induced hypoglycemia on IGF-1 bioactivity as possible mechanisms. In a double-blind placebo-controlled study, glucagon was intramuscularly administrated in 13 type 1 diabetic patients (6 males /7 females; [BMI]: 24.8 ± 0.95 kg/m2), 11 obese subjects (OP; 5/ 6; 34.4 ± 1.7 kg/m2), and 13 healthy lean participants (LP; 6/ 7; 21.7 ± 0.6 kg/m2), whereas 12 obese subjects (OP; 6/ 6; 34.4 ± 1.7 kg/m2), and 13 healthy lean participants (LP; 6/ 7; 21.7 ± 0.6 kg/m2) performed insulin tolerance test in another double-blind placebo-controlled study and changes in GH, total IGF-1, IGF binding proteins (IGFBPs) and IGF-1 bioactivity, measured by the cell-based KIRA method, were investigated. In addition, the interaction between the metabolic hormones (glucagon and insulin) and the GH-IGF-1 system on the transcriptional level was studied using mouse primary hepatocytes. In this thesis, glucagon decreased IGF-1 bioactivity in humans independently of endogenous insulin levels, most likely through modulation of IGFBP-1 and-2 levels. The glucagon-induced reduction in IGF-1 bioactivity may represent a novel mechanism underlying the impact of glucagon on GH secretion and may explain the negative effect of high protein diet related to increased cardiovascular risk and mortality rate. In addition, insulin-induced hypoglycemia was correlated with a decrease in IGF-1 bioactivity through up-regulation of IGFBP-2. These results may refer to a possible and poorly explored mechanism explaining the strong association between hypoglycemia and increased cardiovascular mortality among diabetic patients.
The stems of Abrus precatorius were used to extract a beta-amylase enriched fraction. A three phase partitioning method and a Doehlert design with 3 variables (ratio of crude extract/t-butanol, the ammonium sulphate saturation and pH) were used. The data was fitted in a second-order polynomial model and the parameters were optimized to enrich beta-amylase. Experimental responses for the modulation were recovery of activity and the purification factor. The optimal conditions were: a ratio of crude extract/t-butanol of 0.87 (v/v), saturation in ammonium sulphate of 49.46% (w/v) and a pH of 5.2. An activity recovery of 156.2% and a purification factor of 10.17 were found. The enriched enzyme was identified as a beta-amylase and its molecular weight was 60.1 kDa. K-m and V-max values were 79.37 mg/ml and 5.13 U/ml, respectively and the highest activity was registered at a temperature of 70 degrees C and a pH between 6 and 6.5. A significant stabilization of the beta-amylase was observed up to 65 degrees C. (C) 2015 Elsevier Ltd. All rights reserved.